Expert Analysis

Early Breast Cancer

Source: CCO Independent Conference Coverage of the 2008 San Antonio Breast Cancer Symposium*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Early Breast Cancer

Moderator: Robert S. Mocharnuk, MD

Faculty:

Harold J. Burstein, MD, PhD
Peter Ravdin, MD, PhD
Hope S. Rugo, MD

CREDIT INFORMATION

Release Date: 03/02/09

Expiration Date: 03/01/10

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.0 Nursing contact hour

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe strategies used in the treatment of patients with hormone receptor–positive early breast cancer
Explain the use of gene expression profiling in the setting of early breast cancer
Discuss the use of agents used to mitigate bone loss in breast cancer patients receiving aromatase inhibitors
Summarize recent clinical data regarding chemotherapy combinations used to treat patients with early breast cancer

Topics covered include:

Hormone-Switch Therapies in Early Breast Cancer
The BIG 1-98 Trial: Letrozole vs Tamoxifen
TEAM Trial and ABCSG 8
Bisphosphonates in Breast Cancer
Prognostic Tools
Tamoxifen Metabolism
Optimizing Chemotherapy in Early Breast Cancer

Abstract

Click here to view abstract

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.